Hugo R. Rosen
About
Hugo R. Rosen is a scholar working on Hepatology, Epidemiology and Immunology.
According to data from OpenAlex, Hugo R. Rosen has authored 196 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Hepatology, 95 papers in Epidemiology and 67 papers in Immunology. Recurrent topics in Hugo R. Rosen's work include Hepatitis C virus research (91 papers), Liver Disease Diagnosis and Treatment (65 papers) and Immune Cell Function and Interaction (49 papers). Hugo R. Rosen is often cited by papers focused on Hepatitis C virus research (91 papers), Liver Disease Diagnosis and Treatment (65 papers) and Immune Cell Function and Interaction (49 papers). Hugo R. Rosen collaborates with scholars based in United States, France and Japan. Hugo R. Rosen's co-authors include Lucy Golden‐Mason, Kent G. Benner, Kenneth D. Flora, Paul Martin, David R. Gretch, Martin Hahn, John M. Rabkin, Jared Klarquist, Nicole Castelblanco and Christopher L. Corless and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
In The Last Decade
Hugo R. Rosen
195 papers receiving 13.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hugo R. Rosen United States | 62 | 7.9k | 6.8k | 3.9k | 2.1k | 1.5k | 196 | 13.8k | ||
| Ulrich Spengler Germany | 65 | 9.4k 1.2× | 8.3k 1.2× | 3.0k 0.8× | 1.7k 0.8× | 1.1k 0.8× | 396 | 14.9k | ||
| Graeme Alexander United Kingdom | 49 | 7.2k 0.9× | 7.2k 1.0× | 1.8k 0.5× | 1.6k 0.7× | 1.3k 0.9× | 191 | 11.9k | ||
| Claude Degott France | 77 | 8.3k 1.0× | 8.3k 1.2× | 2.1k 0.5× | 3.3k 1.5× | 2.7k 1.8× | 318 | 18.1k | ||
| Mark Thursz United Kingdom | 61 | 6.2k 0.8× | 7.5k 1.1× | 1.5k 0.4× | 1.5k 0.7× | 1.7k 1.1× | 317 | 12.5k | ||
| Diego Vergani United Kingdom | 73 | 12.4k 1.6× | 11.2k 1.6× | 4.0k 1.0× | 4.1k 1.9× | 1.2k 0.8× | 417 | 19.0k | ||
| Michio Sata Japan | 58 | 7.1k 0.9× | 6.8k 1.0× | 1.2k 0.3× | 2.6k 1.2× | 3.1k 2.1× | 457 | 15.1k | ||
| Ansgar W. Lohse Germany | 74 | 12.4k 1.6× | 10.8k 1.6× | 3.0k 0.8× | 4.3k 2.0× | 1.9k 1.3× | 485 | 19.5k | ||
| Raymond T. Chung United States | 79 | 13.5k 1.7× | 12.9k 1.9× | 3.1k 0.8× | 1.9k 0.9× | 3.7k 2.5× | 431 | 23.1k | ||
| Jenny Heathcote Canada | 53 | 10.0k 1.3× | 9.9k 1.4× | 909 0.2× | 1.7k 0.8× | 710 0.5× | 175 | 12.6k | ||
| Masahiro Kobayashi Japan | 57 | 11.3k 1.4× | 9.8k 1.4× | 854 0.2× | 1.4k 0.7× | 1.7k 1.1× | 473 | 15.3k |
Countries citing papers authored by Hugo R. Rosen
Since
Specialization
Citations
This map shows the geographic impact of Hugo R. Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo R. Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo R. Rosen more than expected).
Fields of papers citing papers by Hugo R. Rosen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hugo R. Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo R. Rosen. The network helps show where Hugo R. Rosen may publish in the future.
Co-authorship network of co-authors of Hugo R. Rosen
This figure shows the co-authorship network connecting the top 25 collaborators of Hugo R. Rosen. A scholar is included among the top collaborators of Hugo R. Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo R. Rosen. Hugo R. Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Burchill, Matthew A., Austin E. Gillen, Rachel H. McMahan, et al.. (2020). Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System. Cellular and Molecular Gastroenterology and Hepatology. 11(2). 573–595.
2.
Noureddin, Mazen, Shira Zelber‐Sagi, Lynne R. Wilkens, et al.. (2019). Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort. Hepatology. 71(6). 1940–1952.
3.
Giugliano, Silvia, Margaret G. Petroff, Susmita Jasti, et al.. (2015). Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission. The Journal of Immunology. 195(8). 3737–3747.
4.
Stone, Amy E.L., Silvia Giugliano, Gretja Schnell, et al.. (2013). Correction: Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells. PLoS Pathogens. 9(6).
5.
Tacke, Robert, et al.. (2011). Myeloid Suppressor Cells Induced by Hepatitis C Virus Suppress T-Cell Responses Through the Production of Reactive Oxygen Species. Hepatology. 55(2). 343–353.
6.
Hughes, Austin L., Susan McArdle, Stephen Livingston, et al.. (2011). Genetic Diversity of Near Genome-Wide Hepatitis C Virus Sequences during Chronic Infection: Evidence for Protein Structural Conservation Over Time. PLoS ONE. 6(5). e19562–e19562.
7.
Golden‐Mason, Lucy, Kiran Bambha, Linling Cheng, et al.. (2011). Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology. 54(5). 1559–1569.
8.
Mengshol, John A., Lucy Golden‐Mason, Tomohiro Arikawa, et al.. (2010). Correction: A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection. PLoS ONE. 5(3).
9.
McMahan, Rachel H., Lucy Golden‐Mason, Michael I. Nishimura, et al.. (2010). Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. Journal of Clinical Investigation. 120(12). 4546–4557.
10.
Benson, Alexander B., James R. Burton, Gregory L. Austin, et al.. (2010). Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transplantation. 17(2). 149–158.
11.
Golden-Mason, Lucy, Brent E. Palmer, Nasim Kassam, et al.. (2009). Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4 + and CD8 + T Cells. Journal of Virology. 83(18). 9122–9130.
12.
Mengshol, John A., Lucy Golden‐Mason, Nicole Castelblanco, et al.. (2009). Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut. 58(7). 964–973.
13.
Golden-Mason, Lucy, Jared Klarquist, Abdus S. Wahed, & Hugo R. Rosen. (2008). Cutting Edge: Programmed Death-1 Expression Is Increased on Immunocytes in Chronic Hepatitis C Virus and Predicts Failure of Response to Antiviral Therapy: Race-Dependent Differences. The Journal of Immunology. 180(6). 3637–3641.
14.
Golden‐Mason, Lucy, Nicole Castelblanco, Cliona O’Farrelly, & Hugo R. Rosen. (2007). Phenotypic and Functional Changes of Cytotoxic CD56 pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection. Journal of Virology. 81(17). 9292–9298.
15.
Rosen, Hugo R., David J. Hinrichs, Rachel L. Leistikow, et al.. (2004). Cutting Edge: Identification of Hepatitis C Virus-Specific CD8+ T Cells Restricted by Donor HLA Alleles following Liver Transplantation. The Journal of Immunology. 173(9). 5355–5359.
16.
Rosen, Hugo R., Anna W. Sasaki, David Lewinsohn, et al.. (2002). Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages. Hepatology. 35(1). 190–198.
17.
Rosen, Hugo R., et al.. (2000). Primer on Hepatitis C for Hospital Epidemiologists. Infection Control and Hospital Epidemiology. 21(3). 229–234.
18.
Rosen, Hugo R., David J. Hinrichs, David R. Gretch, et al.. (1999). Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology. 117(4). 926–932.
19.
Rosen, Hugo R., Kent G. Benner, Kenneth D. Flora, et al.. (1997). DEVELOPMENT OF GANCICLOVIR RESISTANCE DURING TREATMENT OF PRIMARY CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION1. Transplantation. 63(3). 476–478.
20.
Demetriou, Achilles A., Jacek Rózga, Luis G. Podestá, et al.. (1995). Early Clinical Experience with a Hybrid Bioartificial Liver. Scandinavian Journal of Gastroenterology. 30(sup208). 111–117.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ulrich Spengler Breakdown of academic impact, for papers by Graeme Alexander Breakdown of academic impact, for papers by Claude Degott Breakdown of academic impact, for papers by Mark Thursz Breakdown of academic impact, for papers by Diego Vergani Breakdown of academic impact, for papers by Michio Sata Breakdown of academic impact, for papers by Ansgar W. Lohse Breakdown of academic impact, for papers by Raymond T. Chung Breakdown of academic impact, for papers by Jenny Heathcote Breakdown of academic impact, for papers by Masahiro Kobayashi